Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
06821 ASYMCHEM
129.600-2.900-2.19%
Closed
02/03 16:08 CCT
High
135.000
Open
135.000
Turnover
24.30M
Low
127.300
Pre Close
132.500
Volume
187.62K
Price Forecast
News
Comment
Asymchem Laboratories Forecasts Up to 213% Rise in FY22 Profit
02:58 AM EST, 01/31/2023 (MT Newswires) -- Asymchem Laboratories (Tianjin) (HKG:6821, SHE:002821) expects its attributable profit to increase 208% to 213% to 3.29 billion yuan to 3.35 billion yuan in
Gloria Ying: Positive Profit Alert
Private Companies Own 33% of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Shares but Individual Investors Control 35% of the Company
To get a sense of who is truly in control of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821), it is important to understand the ownership structure of the business. With 35% stake, individual
Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Stock Is Going Strong: Is the Market Following Fundamentals?
Asymchem Laboratories (Tianjin)'s (SZSE:002821) stock is up by a considerable 12% over the past week. Since the market usually pay for a company's long-term fundamentals, we decided to study the com
Asymchem Announces Opening of R&D Site Near Boston, Massachusetts
TEDA TIANJIN, P.R. China, Dec. 19, 2022 /PRNewswire/ -- Asymchem Laboratories (Tianjin) Co., Ltd. (stock code: 002821.SZ/6821.HK) ("Asymchem"), a leading CDMO serving the global pharmaceutical and b
Those Who Invested in Asymchem Laboratories (Tianjin) (SZSE:002821) Five Years Ago Are up 244%
It might be of some concern to shareholders to see the Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) share price down 12% in the last month. But that doesn't change the fact that the retu
If EPS Growth Is Important To You, Asymchem Laboratories (Tianjin) (SZSE:002821) Presents An Opportunity
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage
Analysts Have Been Trimming Their Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Price Target After Its Latest Report
It's been a good week for Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) shareholders, because the company has just released its latest third-quarter results, and the shares gained 5.1% to CN
Nomura Adjusts Asymchem Laboratories Tianjin's Price Target to HK$132.67 From HK$131.85, Keeps at Buy
Kellein: third quarter report 2022
Company Overview
More
The company (stock code: 002821.SZ/6821.HK) is a world-leading CDMO company, providing high-quality one-stop services for R&D and production of new drugs worldwide. It is our mission to accelerate the launch of new drugs and extend the quality of life. Relying on continuous technological innovation, we provide domestic and foreign pharmaceutical companies and biotechnology companies with one-stop CMC services for the full life cycle of drugs to accelerate the development and application of new drugs. The company is a world-leading, technology-driven CDMO one-stop integrated service provider. Accelerate clinical research and commercial application of innovative drugs by providing domestic and foreign pharmaceutical companies and biotechnology companies with one-stop CMC services for the full life cycle of drugs and efficient and high-quality R&D and production services. By providing domestic and foreign pharmaceutical companies and biotechnology companies with one-stop CMC services for the full life cycle of pharmaceuticals, efficient and high-quality R&D and production services in 2019, the company won the “2018 Best Partner for the Transformation and Upgrading of Chinese Pharmaceutical Enterprises”. A total of 6 winning enterprises/institutions were selected in this selection. As the only pharmaceutical CDMO company on the list, the company won the award through a hierarchical screening process for its excellent quality and service, good reputation and reputation - this is another time the company won this honor. It won the “China Pharmaceutical Industry Top 100” and “Top 20 Pharmaceutical Outsourcing Companies in China” awards in the “2018 China Pharmaceutical Industry Most Influential List” issued by the Pharmaceutical Chamber of Commerce of the All-China Federation of Industry and Commerce, fully demonstrating the company's strong competitiveness and strong growth as an industry benchmark.
CEO： Hao Hong
Market： Hong Kong motherboard
Listing Date： 12/10/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet